Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus

European Journal of Cancer

Volumn 37, Issue 4, 2001, Pages 470-477

  Wobbes, Th ^a   Baron, B ^b   Paillot, B ^c   Jacob, J H ^d   Haegele, P ^e   Gignoux, M ^f   Michel, P ^c   Couvreur, M L ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c HÔPITAL CHARLES NICOLLE   (France)

^d CENTRE FRANÇOIS BACLESSE   (France)

^e CENTRE PAUL STRAUSS   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Chemotherapy; Cisplatin; Oesophageal cancer; Split course irradiation; Squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0035087358     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00399-3     Document Type: Article

References (16)

1. A prospective randomized study of various irradiation doses and fractionating schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
2. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer
3. Split-course radiotherapy in the treatment of carcinoma of the esophagus
4. Nonparametric estimation from incomplete observations
5. Evaluation of survival data and two new rank order statistics arising in its consideration
6. Regression models and life-tables
7. Chemotherapy and combined-modality therapy for esophageal cancer
8. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary
9. Chemotherapy in esophageal cancer
10. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
11. Platinum complexes as radiosenzitizers of hypoxic mammalian cells
12. Potentiation of the radiation response of hypoxic mammalian cells by cis-dichlorobis(isopropylamine) trans-hydroxy platinum
13. Combined cis-platinum plus radiation antitumor activity in locoregionally advanced squamous cell esophageal cancer
14. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)
15. The required size and length of a phase III clinical trial
16. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial